Page last updated: 2024-10-24

negative regulation of neurotrophin TRK receptor signaling pathway

Definition

Target type: biologicalprocess

Any process that stops, prevents, or reduces the frequency, rate or extent of the neurotrophin TRK receptor signaling pathway. [GOC:ai]

Negative regulation of neurotrophin TRK receptor signaling pathway involves a complex interplay of molecular mechanisms that fine-tune the cellular response to neurotrophins, a family of growth factors crucial for neuronal survival, differentiation, and synaptic plasticity. This intricate process is essential for maintaining neuronal homeostasis and preventing aberrant signaling that could lead to neurological disorders.

Key players in negative regulation include:

1. **Receptor Internalization and Degradation:** After neurotrophin binding, TRK receptors undergo endocytosis, a process by which they are internalized into the cell. This can lead to receptor degradation in lysosomes, reducing the number of available receptors at the cell surface.

2. **Protein Kinase Regulation:** TRK receptor activation triggers downstream signaling cascades involving various protein kinases. Negative regulators, such as protein tyrosine phosphatases (PTPs), dephosphorylate activated kinases, effectively dampening their activity and reducing signal propagation.

3. **Feedback Loops:** TRK signaling itself can induce the expression of negative regulators. For example, activated TRK receptors can activate transcription factors that promote the production of proteins that inhibit further signaling.

4. **Adaptor Protein Interaction:** Specific adaptor proteins, such as SH2 domain-containing protein tyrosine phosphatase 1 (SHP-1), can bind to activated TRK receptors and recruit other signaling molecules that suppress the pathway.

5. **Ubiquitination and Proteasomal Degradation:** TRK receptors can be targeted for ubiquitination, a process that marks them for degradation by the proteasome, a cellular machinery responsible for protein breakdown.

These intricate mechanisms work in concert to ensure that neurotrophin signaling is tightly controlled, preventing excessive or inappropriate activation that could disrupt neuronal function. Dysregulation of negative regulation has been implicated in neurological disorders such as Alzheimer's disease and cancer.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Type-2 angiotensin II receptorAn angiotensin II receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P50052]Homo sapiens (human)

Compounds (29)

CompoundDefinitionClassesRoles
5-iodo-2-(oxaloamino)benzoic acidorganoiodine compound
candesartancandesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

candesartan: a nonpeptide angiotensin II receptor antagonist
benzimidazolecarboxylic acid;
biphenylyltetrazole
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
avaproirbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
azaspiro compound;
biphenylyltetrazole
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
losartanlosartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
biphenylyltetrazole;
imidazoles
angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
miconazole1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group.

miconazole : A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.

Miconazole: An imidazole antifungal agent that is used topically and by intravenous infusion.
dichlorobenzene;
ether;
imidazoles
ipsapironeN-arylpiperazine
flesinoxan
valsartanvalsartan : A monocarboxylic acid amide consisting of L-valine in which the amino hydrogens have been replaced by a pentanoyl and a [2'-(1H-tetrazol-5-yl)biphenyl]-4-yl]methyl group. It exhibits antihypertensive activity.

Valsartan: A tetrazole derivative and ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to treat HYPERTENSION.
biphenylyltetrazole;
monocarboxylic acid;
monocarboxylic acid amide
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
telmisartantelmisartan : A member of the class of benzimidazoles used widely in the treatment of hypertension.

Telmisartan: A biphenyl compound and benzimidazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION.
benzimidazoles;
biphenyls;
carboxybiphenyl
angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
bexarotenebenzoic acids;
naphthalenes;
retinoid
antineoplastic agent
exp7711EXP7711: to search, use E#P7711(nm); angiotensin II receptor antagonist; structure given in first source
bibs 39BIBS 39: structure given in first source; angiotensin II receptor antagonist
a 81988A 81988: angiotensin II antagonist selective for type 1 receptors
bibs 222BIBS 222: structure given in first source; angiotensin II receptor antagonist
chrysamine gchrysamine G: structure given in first source; RN refers to disodium salt
angiotensin iiGiapreza: injectable form of angiotensin II used to increase blood pressure in adult patients with septic or other distributive shock

Ile(5)-angiotensin II : An angiotensin II that acts on the central nervous system (PDB entry: 1N9V).
amino acid zwitterion;
angiotensin II
human metabolite
l 158809L 158809: RN & structure given in first source; angiotensin receptor antagonist
2-(oxaloamino)benzoic acid(oxaloamino)benzoic acid
alitretinoinAlitretinoin: A retinoid that is used for the treatment of chronic hand ECZEMA unresponsive to topical CORTICOSTEROIDS. It is also used to treat cutaneous lesions associated with AIDS-related KAPOSI SARCOMA.retinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist
tak 013
pd 123319PD123319 : An imidazopyridine consisting of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine having 4-(dimethylamino)-3-methylbenzyl, diphenylacetyl and carboxy and groups at positions 1, 5 and 6 respectivelyimidazopyridineangiotensin receptor antagonist;
endothelin receptor antagonist;
vasoconstrictor agent
exp 655
saralasinSaralasin: An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION.oligopeptide
l 162313L 162313: a biphenylimidazole derivative; a non-peptide angiotensin agonist; no further information available 2/95
l 163491L 163491: structure given in first source
nrx 194204IRX4204: retinoid X receptor (RXR) agonist; structure in first source
agn 194204AGN 194204: a retinoid X receptor ligand; structure in first source
ema401
naluzotannaluzotan: an antidepressant and anti-anxiety agent; structure in first source